Publication: 4013

Publication: 4013

Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Breast Cancer Res vol 27 (1) 26

Year:: 2025
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub-ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 15

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA232760, UG1CA233253, UG1CA233329

Corr. Author:
Authors:: Jeffrey R. Marks Dadong Zhang Timothy Hardman Yunn-yi Chen Allison Hall Lunden Simpson Tina Hieken Isabelle Bedrosian Elissa Price Jeff Sheng Yanwan Dai Marissa Lee Alexander B. Sibley Kouros Owzar E. Shelley Hwang

Networks:: LAPS-MN026, LAPS-NC010, LAPS-TX035

Study: CALGB-40903
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: